Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States

Ann Epidemiol. 2018 Dec;28(12):830-832. doi: 10.1016/j.annepidem.2018.08.005. Epub 2018 Aug 24.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / therapeutic use
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / administration & dosage*
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Pre-Exposure Prophylaxis / methods*
  • Pre-Exposure Prophylaxis / statistics & numerical data*
  • Pre-Exposure Prophylaxis / trends
  • United States

Substances

  • Anti-HIV Agents
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination